🍽️ olanzapine,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations   |   βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of olanzapine,(prescription) On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Reduces
species Lactobacillus acidophilus Increases
species Lactobacillus crispatus Increases
species Lactobacillus gasseri Increases
species Lactobacillus helveticus Increases
species Lactobacillus jensenii Increases
species Lactobacillus johnsonii Increases
species Lactobacillus kefiranofaciens Increases

Bacteria Impacted by olanzapine,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Lactobacillaceae family Increases 👪 Source Study
Caenorhabditis genus Decreases 📓 Source Study
Agathobacter genus Decreases 👪 Source Study
Eggerthella genus Decreases 👪 Source Study
Akkermansia genus Decreases 👪 Source Study
Thomasclavelia genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Bacteroides genus Decreases 👪 Source Study
Lachnospira genus Decreases 👪 Source Study
Phocaeicola genus Decreases 👪 Source Study
Lactobacillus genus Increases 👪 Source Study Pathogen
Lactobacillus genus Increases 📓 Source Study Pathogen
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Lactobacillus no rank Increases 👶 Source Study
Eggerthellales order Decreases ⚗️ Source Study
Agathobacter rectalis species Decreases 📓 Source Study
Eggerthella lenta species Decreases 📓 Source Study
Akkermansia muciniphila species Decreases 📓 Source Study
Thomasclavelia ramosa species Decreases 📓 Source Study
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
Caenorhabditis briggsae species Decreases 👶 Source Study
Caenorhabditis elegans species Decreases 👶 Source Study
Caenorhabditis inopinata species Decreases 👶 Source Study
Caenorhabditis remanei species Decreases 👶 Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Roseburia intestinalis species Decreases 📓 Source Study
Bacteroides xylanisolvens species Decreases 📓 Source Study
Lachnospira eligens species Decreases 📓 Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
ATCC 15434 species Increases 👶 Source Study
Lactobacillus acetotolerans species Increases 👶 Source Study
Lactobacillus acidophilus species Increases 👶 Source Study
Lactobacillus alvei species Increases 👶 Source Study
Lactobacillus amylolyticus species Increases 👶 Source Study
Lactobacillus amylovorus species Increases 👶 Source Study
Lactobacillus animata species Increases 👶 Source Study
Lactobacillus apis species Increases 👶 Source Study
Lactobacillus bombicola species Increases 👶 Source Study
Lactobacillus brevisimilis species Increases 👶 Source Study
Lactobacillus crispatus species Increases 👶 Source Study
Lactobacillus delbrueckii species Increases 👶 Source Study
Lactobacillus equicursoris species Increases 👶 Source Study
Lactobacillus faeni species Increases 👶 Source Study
Lactobacillus fornicalis species Increases 👶 Source Study
Lactobacillus gallinarum species Increases 👶 Source Study
Lactobacillus gasseri species Increases 👶 Source Study
Lactobacillus gigeriorum species Increases 👶 Source Study
Lactobacillus guizhouensis species Increases 👶 Source Study
Lactobacillus hamsteri species Increases 👶 Source Study
Lactobacillus helsingborgensis species Increases 👶 Source Study
Lactobacillus helveticus species Increases 👶 Source Study
Lactobacillus hominis species Increases 👶 Source Study
Lactobacillus iners species Increases 👶 Source Study
Lactobacillus intermedius species Increases 👶 Source Study
Lactobacillus intestinalis species Increases 👶 Source Study depression, anhedonia
Lactobacillus japonicus species Increases 👶 Source Study
Lactobacillus jensenii species Increases 👶 Source Study
Lactobacillus johnsonii species Increases 👶 Source Study
Lactobacillus kalixensis species Increases 👶 Source Study
Lactobacillus kefiranofaciens species Increases 👶 Source Study
Lactobacillus kitasatonis species Increases 👶 Source Study
Lactobacillus kullabergensis species Increases 👶 Source Study
Lactobacillus leichmannii species Increases 👶 Source Study
Lactobacillus letivazi species Increases 👶 Source Study
Lactobacillus panisapium species Increases 👶 Source Study
Lactobacillus paragasseri species Increases 👶 Source Study
Lactobacillus pasteurii species Increases 👶 Source Study
Lactobacillus psittaci species Increases 👶 Source Study
Lactobacillus rodentium species Increases 👶 Source Study
Lactobacillus rogosae species Increases 👶 Source Study
Lactobacillus selangorensis species Increases 👶 Source Study
Lactobacillus sp. 7_1_47FAA species Increases 👶 Source Study
Lactobacillus sp. MYMRS/TEN2 species Increases 👶 Source Study
Lactobacillus taiwanensis species Increases 👶 Source Study
Lactobacillus terrae species Increases 👶 Source Study
Lactobacillus ultunensis species Increases 👶 Source Study
Lactobacillus gasseri species Increases 📓 Source Study
Lactobacillus casei group species group Increases 👶 Source Study
Lactobacillus gasseri 202-4 strain Increases 👶 Source Study
Lactobacillus gasseri ATCC 33323 = JCM 1131 strain Increases 👶 Source Study
Lactobacillus gasseri DSM 14869 strain Increases 👶 Source Study
Peloderinae subfamily Decreases 👪 Source Study
Coriobacterineae suborder Decreases ⚗️ Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of olanzapine,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.4 0.4
ADHD 0.8 0.2 3
Age-Related Macular Degeneration and Glaucoma 0 0
Allergic Rhinitis (Hay Fever) 0.5 0.5
Allergies 1 0.3 2.33
Allergy to milk products 0 0
Alzheimer's disease 0.5 1 -1
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.5 0.7 -0.4
Ankylosing spondylitis 0.4 0 0
Anorexia Nervosa 0.4 -0.4
Antiphospholipid syndrome (APS) 0.1 0.1
Asthma 0.8 0.5 0.6
Atherosclerosis 0.7 -0.7
Atrial fibrillation 0.4 0.5 -0.25
Autism 1.4 2 -0.43
Bipolar Disorder 0 0.3 0
Brain Trauma 0.4 0.1 3
Carcinoma 0.3 0 0
Celiac Disease 0 0.6 0
Cerebral Palsy 0.1 0.1 0
Chronic Fatigue Syndrome 1.3 0 0
Chronic Kidney Disease 0.7 0.7 0
Chronic Lyme 0.1 -0.1
Chronic Obstructive Pulmonary Disease (COPD) 0 0
Chronic Urticaria (Hives) 0.3 -0.3
Coagulation / Micro clot triggering bacteria 0 0
Colorectal Cancer 0.1 0.7 -6
Constipation 0.1 0 0
Coronary artery disease 0.3 0.3
COVID-19 1.7 2.5 -0.47
Crohn's Disease 0.9 1.4 -0.56
cystic fibrosis 0.1 -0.1
deep vein thrombosis 0 0
Depression 2.2 2.6 -0.18
Eczema 0.3 0.3
Endometriosis 0.8 0 0
Epilepsy 0.6 0.5 0.2
Fibromyalgia 0.7 0 0
Functional constipation / chronic idiopathic constipation 0.6 0.1 5
gallstone disease (gsd) 0.3 -0.3
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.4 0.4
Generalized anxiety disorder 0 0
Graves' disease 0 0.5 0
Halitosis 0 0
Hashimoto's thyroiditis 0.5 0 0
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.4 0.9 -1.25
hypercholesterolemia (High Cholesterol) 0.3 -0.3
hyperglycemia 0.4 0.5 -0.25
Hyperlipidemia (High Blood Fats) 0.9 0.9
hypertension (High Blood Pressure 0.6 0.6 0
Hypothyroidism 0.2 -0.2
Hypoxia 0.2 0.4 -1
IgA nephropathy (IgAN) 0.4 0 0
Inflammatory Bowel Disease 0.9 2 -1.22
Insomnia 0 0.7 0
Intracranial aneurysms 0.5 0.5
Irritable Bowel Syndrome 0.8 0.8 0
Liver Cirrhosis 0.6 0.6 0
Long COVID 1.5 1.2 0.25
Low bone mineral density 0 0
Lung Cancer 0.3 -0.3
ME/CFS with IBS 0 0
ME/CFS without IBS 0.8 0 0
Metabolic Syndrome 0.9 1.2 -0.33
Mood Disorders 2.5 3.2 -0.28
multiple chemical sensitivity [MCS] 0.1 0.4 -3
Multiple Sclerosis 1.8 1.2 0.5
Multiple system atrophy (MSA) 0.4 0.4 0
Neuropathy (all types) 0.1 0.4 -3
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.3 -1.3
Obesity 0.2 0.9 -3.5
obsessive-compulsive disorder 0.5 0.6 -0.2
Osteoarthritis 0.3 0.3
Osteoporosis 0.7 0.8 -0.14
Parkinson's Disease 1.3 1.2 0.08
Polycystic ovary syndrome 0 0.6 0
Psoriasis 0.1 0.8 -7
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.2 0.8 0.5
Rosacea 0.4 0 0
Schizophrenia 0.6 0.9 -0.5
scoliosis 0 0
Sjögren syndrome 0.5 -0.5
Sleep Apnea 0.3 -0.3
Stress / posttraumatic stress disorder 0.2 1.2 -5
Systemic Lupus Erythematosus 1 0.5 1
Tic Disorder 0 0
Tourette syndrome 0.6 0 0
Type 1 Diabetes 0.5 0.1 4
Type 2 Diabetes 0.9 1.2 -0.33
Ulcerative colitis 0 1.3 0
Unhealthy Ageing 0.5 1.3 -1.6

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)